Planned hematopoietic stem cell transplantation in a 17‐month‐old patient with high‐risk acute myeloid leukemia and persistent SARS‐CoV‐2 infection
- 8 March 2021
- journal article
- letter
- Published by Wiley in Transfusion
- Vol. 61 (5), 1657-1659
- https://doi.org/10.1111/trf.16361
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- The great challenge of managing recipients of hematopoietic stem cell transplantation combined with COVID-19Bone Marrow Transplantation, 2021
- Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic reviewEmergencias, 2020
- Favourable outcome of coronavirus disease 2019 in a 1‐year‐old girl with acute myeloid leukaemia and severe treatment‐induced immunosuppressionBritish Journal of Haematology, 2020
- Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemicNature Reviews Clinical Oncology, 2020
- Risk of COVID-19 for patients with cancerThe Lancet Oncology, 2020
- Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid reviewEmergencias, 2020